Skip to main content
Erschienen in: International Cancer Conference Journal 4/2013

01.10.2013 | Case report

Cerebral infarctions as manifestation of ovarian clear cell carcinoma: report of two cases and review of the literature

verfasst von: Hirokazu Naoi, Hiroyuki Hashimoto, Etsuko Kajimoto, Masumi Takeda, Susumu Yoshida, Takashi Miyatake, Takeshi Yokoi, Shigeyuki Isaka, Masaaki Nagamatsu

Erschienen in: International Cancer Conference Journal | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Abstract

Venous thromboembolic events (VTE) may occur before the diagnosis of cancer, and VTE can be a predictor of the subsequent diagnosis of cancer. Stroke as well as VTE may be the first manifestation of a subsequent diagnosis of cancer. We report two cases of patients showing cerebral infarction as the first manifestation of clear cell carcinoma of the ovary. The first case is a 55-year-old woman, who had no significant past medical history, lost her consciousness and was diagnosed with bilateral thalamic infarction according to magnetic resonance imaging results. After the diagnosis of infarction, advanced ovarian clear cell carcinoma was diagnosed at the interval of 4 months. Although an operation for ovarian cancer and 6 cycles of subsequent chemotherapies were executed, a recurrent disease occurred in the abdominal cavity. There also were relapses of infarction accompanied by ovarian cancer progression, and she died of ovarian cancer. The second case was a 62-year-old woman, who had repeated infarction episodes, and at the second infarction episode, her respiratory state also worsened. Computed tomography demonstrated swelling of her left ovary, venous thrombosis in the left femoral vein, and pulmonary arterial embolism. An operation for ovarian cancer was performed and early stage clear cell adenocarcinoma of the left ovary was confirmed by pathology. She has remained without evidence of recurrent cancer for 2 years after the completion of chemotherapy. Once cerebral infarction is diagnosed, a comprehensive search for unknown malignant disease should be performed, particularly ovarian clear cell carcinoma.
Literatur
1.
Zurück zum Zitat Iodice S, Gandini S, Löhr M et al (2008) Venous thromboembolic events and organ-specific occult cancers: a review and meta-analysis. J Thromb Haemost 6:781–788PubMedCrossRef Iodice S, Gandini S, Löhr M et al (2008) Venous thromboembolic events and organ-specific occult cancers: a review and meta-analysis. J Thromb Haemost 6:781–788PubMedCrossRef
2.
Zurück zum Zitat Recio FO, Piver MS, Hempling RE et al (1996) Lack of improved survival plus increase in thromboembolic complications in patients with clear cell carcinoma of the ovary treated with platinum versus nonplatinum-based chemotherapy. Cancer 78:2157–2163PubMedCrossRef Recio FO, Piver MS, Hempling RE et al (1996) Lack of improved survival plus increase in thromboembolic complications in patients with clear cell carcinoma of the ovary treated with platinum versus nonplatinum-based chemotherapy. Cancer 78:2157–2163PubMedCrossRef
3.
Zurück zum Zitat Goff BA, Sainz de la Cuesta R, Muntz HG et al (1996) Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease. Gynecol Oncol 60:412–417PubMedCrossRef Goff BA, Sainz de la Cuesta R, Muntz HG et al (1996) Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease. Gynecol Oncol 60:412–417PubMedCrossRef
4.
Zurück zum Zitat Matsuura Y, Robertson G, Marsden DE et al (2007) Thromboembolic complications in patients with clear cell carcinoma of the ovary. Gynecol Oncol 104:406–410PubMedCrossRef Matsuura Y, Robertson G, Marsden DE et al (2007) Thromboembolic complications in patients with clear cell carcinoma of the ovary. Gynecol Oncol 104:406–410PubMedCrossRef
5.
Zurück zum Zitat Prandoni P, Lensing AW, Büller HR et al (1992) Deep-vein thrombosis and the incidence of subsequent symptomatic cancer. N Engl J Med 327:1128–1133PubMedCrossRef Prandoni P, Lensing AW, Büller HR et al (1992) Deep-vein thrombosis and the incidence of subsequent symptomatic cancer. N Engl J Med 327:1128–1133PubMedCrossRef
6.
Zurück zum Zitat Baron JA, Gridley G, Weiderpass E et al (1998) Venous thromboembolism and cancer. Lancet 351:1077–1080PubMedCrossRef Baron JA, Gridley G, Weiderpass E et al (1998) Venous thromboembolism and cancer. Lancet 351:1077–1080PubMedCrossRef
7.
Zurück zum Zitat Sørensen HT, Mellemkjaer L, Steffensen FH et al (1998) The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism. N Engl J Med 338:1169–1173PubMedCrossRef Sørensen HT, Mellemkjaer L, Steffensen FH et al (1998) The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism. N Engl J Med 338:1169–1173PubMedCrossRef
8.
Zurück zum Zitat Abrey LE, Dalmau JO (1999) Neurologic complications of ovarian carcinoma. Cancer 85:127–133PubMedCrossRef Abrey LE, Dalmau JO (1999) Neurologic complications of ovarian carcinoma. Cancer 85:127–133PubMedCrossRef
9.
Zurück zum Zitat Yeh PS, Lin HJ (2004) Cerebrovascular complications in patients with malignancy: report of three cases and review of the literature. Acta Neurol Taiwan 13:34–38PubMed Yeh PS, Lin HJ (2004) Cerebrovascular complications in patients with malignancy: report of three cases and review of the literature. Acta Neurol Taiwan 13:34–38PubMed
10.
Zurück zum Zitat Borowski A, Ghodsizad A, Gams E (2005) Stroke as a first manifestation of ovarian cancer. J Neurooncol 71:267–269PubMedCrossRef Borowski A, Ghodsizad A, Gams E (2005) Stroke as a first manifestation of ovarian cancer. J Neurooncol 71:267–269PubMedCrossRef
11.
Zurück zum Zitat Aryana A, Esterbrooks DJ, Morris PC (2006) Nonbacterial thrombotic endocarditis with recurrent embolic events as manifestation of ovarian neoplasm. J Gen Intern Med 21:C12–C15PubMedCrossRef Aryana A, Esterbrooks DJ, Morris PC (2006) Nonbacterial thrombotic endocarditis with recurrent embolic events as manifestation of ovarian neoplasm. J Gen Intern Med 21:C12–C15PubMedCrossRef
12.
Zurück zum Zitat Devulapalli S, Pinto N, Gandothra C et al (2012) A rare case of occipital stroke as a consequence of nonbacterial thrombotic endocarditis in ovarian clear cell carcinoma: a case report. Case Rep Neurol 4:84–91PubMedCrossRef Devulapalli S, Pinto N, Gandothra C et al (2012) A rare case of occipital stroke as a consequence of nonbacterial thrombotic endocarditis in ovarian clear cell carcinoma: a case report. Case Rep Neurol 4:84–91PubMedCrossRef
13.
Zurück zum Zitat White RH, Chew HK, Zhou H et al (2005) Incidence of venous thromboembolism in the year before the diagnosis of cancer in 528693 adults. Arch Intern Med 165:1782–1787PubMedCrossRef White RH, Chew HK, Zhou H et al (2005) Incidence of venous thromboembolism in the year before the diagnosis of cancer in 528693 adults. Arch Intern Med 165:1782–1787PubMedCrossRef
14.
Zurück zum Zitat De Cicco M (2004) The prothrombotic state in cancer: pathogenic mechanisms. Crit Rev Oncol Hematol 50:187–196PubMedCrossRef De Cicco M (2004) The prothrombotic state in cancer: pathogenic mechanisms. Crit Rev Oncol Hematol 50:187–196PubMedCrossRef
15.
Zurück zum Zitat Uno K, Homma S, Satoh T et al (2007) Tissue factor expression as a possible determinant of thromboembolism in ovarian cancer. Br J Cancer 96:290–295PubMedCrossRef Uno K, Homma S, Satoh T et al (2007) Tissue factor expression as a possible determinant of thromboembolism in ovarian cancer. Br J Cancer 96:290–295PubMedCrossRef
16.
Zurück zum Zitat Taccone FS, Jeangette SM, Blecic SA (2008) First-ever stroke as initial presentation of systemic cancer. J Stroke Cerebrovasc Dis 17:169–174PubMedCrossRef Taccone FS, Jeangette SM, Blecic SA (2008) First-ever stroke as initial presentation of systemic cancer. J Stroke Cerebrovasc Dis 17:169–174PubMedCrossRef
17.
Zurück zum Zitat Kwon HM, Kang BS, Yoon BW (2007) Stroke as the first manifestation of concealed cancer. J Neurol Sci 258:80–83PubMedCrossRef Kwon HM, Kang BS, Yoon BW (2007) Stroke as the first manifestation of concealed cancer. J Neurol Sci 258:80–83PubMedCrossRef
18.
Zurück zum Zitat Wada Y, Takahashi R, Yanagihara C et al (2007) Paradoxical cerebral embolism as the initial symptom in a patient with ovarian cancer. J Stroke Cerebrovasc Dis 16:88–90PubMedCrossRef Wada Y, Takahashi R, Yanagihara C et al (2007) Paradoxical cerebral embolism as the initial symptom in a patient with ovarian cancer. J Stroke Cerebrovasc Dis 16:88–90PubMedCrossRef
20.
Zurück zum Zitat Lee RJ, Bartzokis T, Yeoh TK et al (1991) Enhanced detection of intracardiac sources of cerebral emboli by transesophageal echocardiography. Stroke 22:734–739PubMedCrossRef Lee RJ, Bartzokis T, Yeoh TK et al (1991) Enhanced detection of intracardiac sources of cerebral emboli by transesophageal echocardiography. Stroke 22:734–739PubMedCrossRef
Metadaten
Titel
Cerebral infarctions as manifestation of ovarian clear cell carcinoma: report of two cases and review of the literature
verfasst von
Hirokazu Naoi
Hiroyuki Hashimoto
Etsuko Kajimoto
Masumi Takeda
Susumu Yoshida
Takashi Miyatake
Takeshi Yokoi
Shigeyuki Isaka
Masaaki Nagamatsu
Publikationsdatum
01.10.2013
Verlag
Springer Japan
Erschienen in
International Cancer Conference Journal / Ausgabe 4/2013
Elektronische ISSN: 2192-3183
DOI
https://doi.org/10.1007/s13691-013-0092-z

Weitere Artikel der Ausgabe 4/2013

International Cancer Conference Journal 4/2013 Zur Ausgabe

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Das sind die führenden Symptome junger Darmkrebspatienten

Darmkrebserkrankungen in jüngeren Jahren sind ein zunehmendes Problem, das häufig längere Zeit übersehen wird, gerade weil die Patienten noch nicht alt sind. Welche Anzeichen Ärzte stutzig machen sollten, hat eine Metaanalyse herausgearbeitet.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.